2025. Development and Characterization of a Novel Sustained-Release Formulation of Glimepiride for Improved Glycemic Control. Journal of Carcinogenesis. 24, 2s (Sep. 2025), 859–866. DOI:https://doi.org/10.64149/J.Carcinog.24.2s.859-866.